These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26658376)

  • 21. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of severe bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017.
    Heppe Montero M; Gil-Prieto R; Walter S; Aleixandre Blanquer F; Gil De Miguel Á
    Hum Vaccin Immunother; 2022 Dec; 18(1):1883379. PubMed ID: 33653212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.
    Yorita KL; Holman RC; Steiner CA; Effler PV; Miyamura J; Forbes S; Anderson LJ; Balaraman V
    Pediatr Infect Dis J; 2007 Dec; 26(12):1081-8. PubMed ID: 18043442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life.
    Pérez-Yarza EG; Moreno-Galdó A; Ramilo O; Rubí T; Escribano A; Torres A; Sardón O; Oliva C; Pérez G; Cortell I; Rovira-Amigo S; Pastor-Vivero MD; Pérez-Frías J; Velasco V; Torres-Borrego J; Figuerola J; Barrio MI; García-Hernández G; Mejías A;
    Pediatr Allergy Immunol; 2015 Dec; 26(8):797-804. PubMed ID: 26031206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meteorologic conditions and respiratory syncytial virus activity.
    Hervás D; Reina J; Hervás JA
    Pediatr Infect Dis J; 2012 Oct; 31(10):e176-81. PubMed ID: 22572747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus.
    Dagan R; Landau D; Haikin H; Tal A
    Pediatr Infect Dis J; 1993 May; 12(5):381-6. PubMed ID: 8327298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of altitude on hospitalizations for respiratory syncytial virus infection.
    Choudhuri JA; Ogden LG; Ruttenber AJ; Thomas DS; Todd JK; Simoes EA
    Pediatrics; 2006 Feb; 117(2):349-56. PubMed ID: 16452353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
    Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus infection and immunoprophylaxis for selected high-risk children in Central Australia.
    Bolisetty S; Wheaton G; Chang AB
    Aust J Rural Health; 2005 Oct; 13(5):265-70. PubMed ID: 16171499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Descriptive epidemiological features of bronchiolitis in a population-based cohort.
    Koehoorn M; Karr CJ; Demers PA; Lencar C; Tamburic L; Brauer M
    Pediatrics; 2008 Dec; 122(6):1196-203. PubMed ID: 19047234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample.
    Suh M; Movva N; Jiang X; Bylsma LC; Reichert H; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S154-S163. PubMed ID: 35968878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
    Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B
    Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variables explaining the duration of hospitalization in children under two years of age admitted with acute airway infections: does respiratory syncytial virus have a direct impact?
    Weigl JA; Puppe W; Schmitt HJ
    Klin Padiatr; 2004; 216(1):7-15. PubMed ID: 14747964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
    Winterstein AG; Knox CA; Kubilis P; Hampp C
    JAMA Pediatr; 2013 Dec; 167(12):1118-24. PubMed ID: 24126903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of age and birth month in infants hospitalized with RSV-confirmed disease in the Valencia Region, Spain.
    Mira-Iglesias A; Demont C; López-Labrador FX; Mengual-Chuliá B; García-Rubio J; Carballido-Fernández M; Tortajada-Girbés M; Mollar-Maseres J; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J;
    Influenza Other Respir Viruses; 2022 Mar; 16(2):328-339. PubMed ID: 34821055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
    Henderson J; Hilliard TN; Sherriff A; Stalker D; Al Shammari N; Thomas HM
    Pediatr Allergy Immunol; 2005 Aug; 16(5):386-92. PubMed ID: 16101930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R; Dooley L; Bruden D; Raelson S; Butler JC
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.